1. Ahmad, I. & Beg, A. Z. 2001 Antimicrobial
and phytochemical studies on 45 Indian
medical plants against multi-drug resistant
human pathogens. 74, 113-123.
2. Aneja, K. R. 2003. Experiments in
Microbiology, Plant Pathology and
Biotechnology. New Age International Ltd.
4th ed. pp. 245-285.
3. Bart, A. E.; Karl, A. H.; Ian, T. P. &
Melissa, H. B. 2011 Investigation of human
Research Article CODEN: IJPRNK ISSN: 2277-8713
Mishra RP, IJPRBS, 2013; Volume 2(5):14-21 IJPRBS
Available Online at www.ijprbs.com
20
pathogen Acinetobacter baumannii under
iron limiting conditions. BMC. Genomics,
12, 126.
4. Candel, F. J.; Calvo, N.; Head, J.; Sanchez,
A.; Matesanz, N.; Culebras, E.; Barrientos, A.
& Picazo, J. 2010 A combination of
tigecycline, colistin & meropenem against
multidrug resistance Acinetobacter
baumannii bacteraemia in a renal
transplant recipient: Pharmacodynamic &
microbiological aspects. Rev Es Quimioter.,
2, 103-108.
5. Dent, L. L.; Marshall, D. R.; Pratap, S.; &
Hulette, R. B. 2010 Multi drug resistant
Acinetobacter baumannii: a descriptive
study in a city hospital. BMC Infec. Dis, 10,
196.
6. Garnacho-Montero, J.; Ortiz-Leyba, C.;
Jimenez-Jimenez, F. J.; Barreto-Almodovar,
A. E.; Garcia-Garmendia, J. L.; Bernabeu-
Wittel, M.; Gallego-Lara, S. L. & Madrezo-
Osuna, J. 2003 Treatment of Multidrug
Resistant Acinetobacter baumannii
Ventillator-Associated Pneumonia (VAP)
with intravenous Colistin: A Comparison
with Imipenem-Suceptible VAP. Clin. Infec.
Dis., 36, 1111-1118.
7. Karageorgopoulos, D. E. & Falagas, M. E.
2008 Current Control and treatment of
multidrug resistant Acinetobacter
baumannii infections. Lancet Infect Dis.,
8(12), 751-62.
8. Mishra, R. P.; Deepak; Singh, S. P. &
Anwar, R, 2011, Study of Culture Conditions
and Antimicrobial Drug Production
Properties of Acinetobacter baumannii. J.
Pharma. Biomed. Sci. 12(16), 1-3.
9. Narisawa, N.; Haruta, S.; Arai, H.; Ishii,
M.; & Igarashi, Y. 2008 Coexistence of
Antibiotic-Producing and Antibiotic-
Sensitive Bacteria in Bio films is Mediated
by Resistant Bacteria. App. Environ.
Microbiol, 3887–3894.
10. Peleg, A. Y.; Seifert, H. & Paterson, D. L.
2008 Acinetobacter baumannii: Emergence
of a successful pathogen. Clin. Micro. Rev.,
21(3), 538-582.
11. Poole, K. 2003 Overcoming multidrug
resistance in Gram negative bacteria. Curr.
Opinion Invest. Drugs. 4(2), 128-139.
12. Tak-chiu W. U., 2011 Carbapenemresistant
or Multidrug-resistant A.
baumannii-a Clinician’s perspective. Med.
Bull. 16(4), 6-9.
13. Tenover, F. C. 2006 Mechanism of
antimicrobial resistance in bacteria. Am. J.
Med., 119(6A), S3-S10.
14. Uraban, C.; Maurer, S. S. & Rahal, J. J.
2003 Consideration in Control and
Treatment of Nosocomial Infection Due to
Multidrug-resistant A. baumannii. Clin.
Infect. Dis. 36(10), 1268-1274.
15. Waters, A. E.; Contente-Cuomo, T.;
Buchhagen, J.; liu CM.; Watson, L.; Pearce,
K.; Foster, J. T.; Bowers, J.; Briebe, E. M.;
Engelthaler, D. M.; Keim, P. S. & Price, L. B.
2011 Multidrug resistance Staphylococcus
Research Article CODEN: IJPRNK ISSN: 2277-8713
Mishra RP, IJPRBS, 2013; Volume 2(5):14-21 IJPRBS
Available Online at www.ijprbs.com
21
aureus US meat & poultry. Clin. Infect. Dis.,
52(10), 1227-30.
16. Yoon, J.; Urban, C.; Terzian, C.; Mariano,
N. & Rahal, J. J. 2004 In vitro Double and
Triple Synergistic Activity of Polymyxin B,
Imipenem, and Rifampin against Multidrug-
Resistant A. baumannii. Am. Soc. Micro.
Antimicro. Agents Chemotherapy, 48(3),
753-757.
Thank you for copying data from http://www.arastirmax.com
